GANCICLOVIR AND HYPERIMMUNOGLOBULIN FOR TREATING CYTOMEGALO-VIRUS INFECTION IN BONE-MARROW TRANSPLANT RECIPIENTS

被引:26
作者
AULITZKY, WE [1 ]
TILG, H [1 ]
NIEDERWIESER, D [1 ]
HACKL, M [1 ]
MEISTER, B [1 ]
HUBER, C [1 ]
机构
[1] UNIV INNSBRUCK, DEPT ANESTHESIOL, A-6020 INNSBRUCK, AUSTRIA
关键词
D O I
10.1093/infdis/158.2.488a
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:488 / 489
页数:2
相关论文
共 3 条
  • [1] RISK-FACTORS FOR CYTOMEGALOVIRUS-INFECTION AFTER HUMAN MARROW TRANSPLANTATION
    MEYERS, JD
    FLOURNOY, N
    THOMAS, ED
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1986, 153 (03) : 478 - 488
  • [2] EFFICACY OF CYTOMEGALOVIRUS IMMUNOGLOBULIN IN MARROW TRANSPLANT RECIPIENTS WITH CYTOMEGALOVIRUS PNEUMONIA
    REED, EC
    BOWDEN, RA
    DANDLIKER, PS
    GLEAVES, CA
    MEYERS, JD
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1987, 156 (04) : 641 - 645
  • [3] ACTIVITY OF 9-[2-HYDROXY-1-(HYDROXYMETHYL)ETHOXYMETHYL]GUANINE IN THE TREATMENT OF CYTOMEGALO-VIRUS PNEUMONIA
    SHEPP, DH
    DANDLIKER, PS
    DEMIRANDA, P
    BURNETTE, TC
    CEDERBERG, DM
    KIRK, LE
    MEYERS, JD
    [J]. ANNALS OF INTERNAL MEDICINE, 1985, 103 (03) : 368 - 373